🇺🇸 FDA
Patent

US 9453019

Linked purine pterin HPPK inhibitors useful as antibacterial agents

granted A61PA61P31/00

Quick answer

US patent 9453019 (Linked purine pterin HPPK inhibitors useful as antibacterial agents) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P31/00